Work

Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Year: 2018

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-17-3761

Authors: Matthew S. Davids, Michael Hallek, William Wierda, Andrew W. Roberts, Stephan Stilgenbauer, Jeffrey A. Jones, John F. Gerecitano, Su Young Kim, Jalaja Potluri, Todd Busman, Andrea Best, Maria E. Verdugo, Elisa Cerri, Monali Desai, Peter Hillmen, John F. Seymour

Institutions: Dana-Farber Cancer Institute, University of Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases, The University of Texas MD Anderson Cancer Center, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, Peter MacCallum Cancer Centre, Universität Ulm, The Ohio State University, Memorial Sloan Kettering Cancer Center, AbbVie (United States), University of Leeds, The University of Melbourne

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2808653175

FWCI: 13.15

Cites: 25

Cited by: 164

Related to: 10